Super Hi to Report Second Quarter 2025 Financial Results on Tuesday, August 26, 2025

Super Hi to Report Second Quarter 2025 Financial Results on Tuesday, August 26, 2025 Earnings Call Scheduled for 8:00 a.m. ET on August 26, 2025 GlobeNewswire August 14, 2025 SINGAPORE, Aug. 14, 2025 (GLOBE NEWSWIRE) — Super Hi International Holding Ltd. (“Super Hi” or the “Company”) (NASDAQ: HDL and HKEX: 9658), a leading Chinese cuisine […]

What dreams are made of – Exclusive interview with dream weaver Wang Chaoge

A report fromchinadaily.com.cn: You've heard the phrase: “getting lost in a good book”. Well, thanks to ingenious architecture, bold artistic devices and carefully-designed theaters, Unique Dream of Red Mansion artistic complex in Langfang, Hebei province, enables fans of the eponymous Chinese classic to do literally just that . The novel written by Cao Xueqin, A

Commitbiz Dubai Office Awarded ISO Certifications

Commitbiz LLC, a leading corporate service provider (CSP) having their head office in Dubai, UAE has been recently awarded prestigious ISO certifications. The recognition comes from authorities like SCK Certifications Pvt. Ltd. and QCAS Certifications Inc. The firm which helps with business incorporation has been granted the ISO 9001 certification for Quality Management Systems and

Resolutions from the Extraordinary General Meeting in Sinch AB (publ)

Sinch held an extraordinary general meeting on Thursday, 14 August 2025 in Stockholm. The meeting resolved, in accordance with the board of directors' proposal, to implement a long term incentive program for up to 625 current and future senior executives, key personnel and other employees within the Sinch group (“LTI 2025”). LTI 2025 consists of

Investigation Underway: Confluent, Inc. (CFLT) – Contact Levi & Korsinsky Over Securities Law Violations

NEW YORK, NY / ACCESS Newswire / August 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Confluent, Inc. ("Confluent, Inc.") (NASDAQ:CFLT) concerning possible violations of federal securities laws. Confluent issued a press release on July 30, 2025, announcing its financial results for the second quarter of 2025 and

Ongoing Investigation: Tronox Holdings plc (TROX) May Have Misled Shareholders – Levi & Korsinsky Investigates

NEW YORK, NY / ACCESS Newswire / August 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tronox Holdings plc ("Tronox Holdings plc") (NYSE:TROX) concerning possible violations of federal securities laws. Tronox issued a press release on July 30, 2025, reporting its financial results for the second quarter of

GEN Korean BBQ Expands Internationally with Three New South Korean Locations

(NasdaqGM:GENK), CERRITOS, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) — GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), owner of GEN Korean BBQ, a fast-growing casual dining concept with an extensive menu and signature “grill at your table” experience, today announced the grand opening of three international locations in South Korea. “We are excited

Max Stock Limited announces an AGM to be held on September 18, 2025

Max Stock Ltd. (TASE: MAXO) (the “Company”)announces an AGM to be held at 10:00AM on September 18, 2025 (date of record: August 28, 2025), at the offices of the Company's external legal counsel Herzog Fox Neeman & Co., 6 Itzhak Sadeh St., Tel Aviv, with the following agenda items: — Discussion on both the Company's

GEN Korean BBQ Expands Internationally with Three New South Korean Locations

GEN Korean BBQ Expands Internationally with Three New South Korean Locations Milestone Marks GEN's Entry into Seoul, South Korea and 55th Location, Signaling Strong Growth and Continued Expansion Momentum GlobeNewswire August 14, 2025 CERRITOS, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) — GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), owner of GEN Korean

Leads Biolabs Announces Completion of Patient Enrollment in Pivotal Trial of Opamtistomig Monotherapy for Extrapulmonary Neuroendocrine Carcinoma

Nanjing LeadsBiolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced the successful completion of patient enrollment in the ongoing single-arm, pivotal registrational clinical trial (CTR20213023) for Opamtistomig (LBL-024), a novel PD-L1/4-1BB bispecific antibody. This marks the world's first registrational clinical trial evaluating an immunotherapy monotherapy for extrapulmonary neuroendocrine carcinoma (EP-NEC). The

Scroll to Top